Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03573310
Title A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

B-cell lymphoma

Advanced Solid Tumor

myelodysplastic syndrome

Therapies

JNJ-64619178

Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN


No variant requirements are available.